PRIME CELLULAR INC
8-K, 1998-06-15
NON-OPERATING ESTABLISHMENTS
Previous: CYRK INC, S-3, 1998-06-15
Next: EMERGING MEXICO FUND INC, DEFA14A, 1998-06-15




                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                       ----------------------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of Report (Date of Earliest Event Reported): May 29, 1998

                              PRIME CELLULAR, INC.
             (Exact name of registrant as specified in its charter)


        DELAWARE                     0-18700               13-3570672
  (State or other jurisdiction    (Commission           (I.R.S. Employer
     of incorporation)            File Number)          Identification No.)



              100 First Stamford Place, Stamford, Connecticut    06902
               (Address of Principal Executive Offices)        (Zip Code)


       Registrant's telephone number, including area code: (203) 327-3620


________________________________________________________________________________
           Former Name or Former Address, if Changed Since Last Report


<PAGE>


Item 2. Acquisition and Disposition of Assets.

     On May 29, 1998, Registrant entered into a Merger Agreement (the "Merger
Agreement), by and among Registrant, Prime Cellular Acquisition Corp., a newly
formed wholly-owned subsidiary of Registrant (the "Subsidiary"), and Cell &
Molecular Technologies, Inc., a Delaware corporation ("CMT"). Pursuant to the
Merger Agreement, on May 29, 1998, the Subsidiary was merged with and into CMT
and all of the outstanding shares of capital stock of CMT were converted into an
aggregate of 1,611,000 shares of Common Stock, par value $.01 per share, of
Registrant (the "Merger"), representing approximately 26.4% (after consummation
of the Merger) of Registrant's issued and outstanding Common Stock (the "Merger
Shares").

     CMT is engaged in the provision of contract research and
development services to the biotechnology and pharmaceutical industries as well
as the manufacture and sale of research products for the biotechnology and
pharmaceutical industries.

     In connection with the Merger:

     1. Registrant increased the number of directors constituting the entire
Board of Directors from three (3) to six (6) members. Joseph K. Pagano
("Pagano"), Frederick R. Adler and Samuel A. Rozzi, the members of the Board of
Directors prior to the Merger are continuing as such and have elected the
following individuals to fill the three vacancies on the Board of Directors
created by such increase: Thomas A. Livelli, the President and Chief Executive
Officer of CMT, Richard Malavarca, a Vice President of CMT, and Dr. Paul Marks,
President of Memorial Sloan-Kettering Cancer Center. Messrs. Livelli, Malavarca,
Adler and Pagano were directors and principal stockholders of CMT prior to the
Merger and Messrs. Adler and Pagano are noteholders of CMT.

     2. Registrant issued options to purchase 115,200 shares of its Common Stock
under its 1990 Stock Option Plan, to holders of options that had been granted
under the Stock Option Plan of CMT. In addition, Registrant reserved options to
purchase up to 273,800 shares of Common Stock for future grant under
Registrant's 1990 Stock Option Plan for employees of CMT.

     3. Each stockholder of CMT receiving Merger Shares agreed not to transfer
or dispose of any of their respective Merger Shares for a period of 24 months
following the Merger.

     The number of Merger Shares issued in the Merger and the other terms of the
Merger were determined by negotiations among the representatives of the
Subsidiary and CMT.

                                       -2-


<PAGE>


     The descriptions of the Merger Agreement and the other agreements described
herein are qualified in their entirety by reference to the copy of the Merger
Agreement and the other agreements which are being filed as exhibits to this
Report and which are incorporated herein by reference.

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

     (a)  Financial Statements of the Business Acquired.

     The required financial information for the business acquired will be filed
under cover of Form 8 within 60 days of the date this Form 8-K was required to
be filed.

     (b)  Pro Forma Financial Information and Exhibits.

     The required pro forma financial information will be filed under cover of
Form 8 within 60 days of the date this Form 8-K was required to be filed.

     (c)  Exhibit 2 - Merger Agreement, dated as of May 29, 1998, by and among
          Registrant, the Subsidiary and CMT. Schedules and attachments are
          listed in the Exhibit Index to this Report and have been omitted
          pursuant to Item 601(2) of Regulation S-B.


Item 8. Change in Fiscal Year

     In connection with the Merger, Registrant adopted the fiscal year of CMT,
which is a calendar year. In accordance with the policy of the Securities and
Exchange Commission set forth in Appendix D, Reverse Acquisitions, no transition
report is required because (a) Registrant, the "legal acquiror," is considered
the "accounting acquiree," (b) CMT, the "legal acquiree," is considered the
"accounting acquiror," and (c) the accounting acquiree has adopted the fiscal
year of the accounting acquiror.

                                       -3-


<PAGE>


                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934,
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                               PRIME CELLULAR, INC.



                                               By:/s/ Joseph K. Pagano
                                                  ---------------------------
                                                  Joseph K. Pagano, President

Date:  June 15, 1998

                                       -4-
<PAGE>


                                 EXHIBIT INDEX


Exhibit               Description                          Sequential Page No.
- -------               -----------                          -------------------

2              Merger Agreement, dated as of May 29, 1998            6
               by and among Registrant, the Subsidiary and CMT

               List of Omitted Exhibits and Schedules
               --------------------------------------
               Exhibit 1.2         Certificate of Merger
               Exhibit 1.3         Alonges to Promissory Notes
               Exhibit 1.4(a)      CMT Certificate of Incorporation
               Exhibit 1.4(b)      CMT By-Laws
               Exhibit 4.9         Lock-Up Agreement
               Exhibit 5.2         Stockholders' Representation Letter
               Exhibit 6.1(f)      Tenzer Greenblatt Opinion
               Exhibit 6.2(h)      Littman Krooks Opinion
               
               Schedule 1.3        Indebtedness
               Schedule 2.2        CMT Stock Ownership
               Schedule 2.6        Litigation
               Schedule 2.12       Properties
               Schedule 2.13       Intellectual Property
               Schedule 2.14       Insurance
               Schedule 2.16       Employment Arrangements
               Schedule 2.17       Certain Business Matters
               Schedule 2.18       Certain Contracts
               Schedule 2.20       Consents





                                                                       EXHIBIT 2

                          AGREEMENT AND PLAN OF MERGER

     AGREEMENT AND PLAN OF MERGER dated as of May 29, 1998 (the "Agreement"), by
and among PRIME CELLULAR, INC., a Delaware corporation ("Prime"); CMT
ACQUISITION CORP., a Delaware corporation and a wholly-owned subsidiary of Prime
("Subsidiary"); and CELL & MOLECULAR TECHNOLOGIES, INC., a Delaware corporation
("CMT").

                              W I T N E S S E T H :

     WHEREAS, CMT is engaged in the manufacture and sale of research products
for the biotechnology and pharmaceutical industries and the provision of
contract research and development services to the biotechnology and
pharmaceutical industries (the "Business");

     WHEREAS, the Boards of Directors of Prime and of Subsidiary, and Prime, as
the stockholder of Subsidiary, as well as the Board of Directors of CMT and the
stockholders of CMT have (or shall have on or before the Effective Date) (a)
determined that it is in the best interests of their respective companies for
Subsidiary to be merged with and into CMT upon the terms and subject to the
conditions set forth herein and (b) approved the merger of Subsidiary with and
into CMT (the "Merger") in accordance with the General Corporation Law of the
State of Delaware ("Delaware Law"), and upon the terms and subject to the
conditions set forth herein.

     NOW, THEREFORE, in consideration of the foregoing and the mutual covenants
and agreements herein contained, and intending to be legally bound hereby, the
parties hereto do hereby agree as follows:

     1. The Merger.

          1.1. The Merger. At the Effective Date (as defined in subsection 1.2),
     and subject to and upon the terms and conditions of this Agreement and
     Delaware Law, Subsidiary shall be merged with and into CMT, the separate
     corporate existence of Subsidiary shall cease, and CMT shall continue as
     the surviving corporation. CMT, as the surviving corporation after the
     Merger, is hereinafter sometimes referred to as the "Surviving
     Corporation."

          1.2. Effective Date. At the Closing as set forth in Section 7 hereof,
     Subsidiary and CMT shall cause the Merger to be consummated by filing a
     Certificate of Merger (the "Certificate of Merger") with the Secretary of
     State of the State of Delaware in the form of Exhibit 1.2 and making such
     other filing as may be required by Delaware Law, in such form as


<PAGE>


     required by and executed in accordance with such laws, which Certificate of
     Merger shall provide for an effective date of 5:00 p.m. E.S.T., May 29,
     1998 (the "Effective Date").

          1.3. Effect of the Merger. At the Effective Date, the effect of the
     Merger shall be as provided in the applicable provisions of Delaware Law.
     Without limiting the generality of the foregoing, and subject thereto, at
     the Effective Date, all the rights, privileges, powers, franchises and all
     property (real, personal and mixed) of Subsidiary and all debts due
     Subsidiary shall vest in CMT, and all debts, liabilities, obligations and
     duties of Subsidiary shall become the debts, liabilities, obligations and
     duties of CMT. In addition, certain of the terms of certain indebtedness of
     CMT listed on Schedule 1.3 in the aggregate principal amount of $500,000
     shall be amended by the issuance of allonges to such promissory notes in
     the form attached hereto as Exhibit 1.3.

          1.4. Certificate of Incorporation; By-Laws.

          (a) The Certificate of Incorporation of CMT, as in effect immediately
     prior to the Effective Date (annexed hereto as Exhibit 1.4(a)), shall be
     the Certificate of Incorporation of the Surviving Corporation until
     thereafter amended as provided by law or such Certificate of Incorporation.

          (b) The By-Laws of CMT, as in effect immediately prior to the
     Effective Date (annexed hereto as Exhibit 1.4(b)), shall be the By-Laws of
     the Surviving Corporation until thereafter amended as provided by law or
     the Certificate of Incorporation of the Surviving Corporation or the
     By-Laws of the Surviving Corporation.

          1.5. Directors and Officers of Prime and Surviving Corporation.

          (a) The Board of Directors of Prime immediately following the
     Effective Date shall have six (6) members, consisting of (i) Joseph K.
     Pagano, Chairman, (ii) Frederick R. Adler, (iii) Samuel A. Rozzi, (iv)
     Thomas J. Livelli, (v) Paul Marks and (vi) Richard Malavarca, each director
     to hold office in accordance with applicable law, the Certificate of
     Incorporation and By-Laws of Prime until their resignation, removal or
     replacement.

          (b) The officers and directors of CMT immediately prior to the Merger
     shall be the officers and directors of the Surviving Corporation
     immediately after the Merger, with each director and officer serving as
     such in accordance with applicable law, the Certificate of Incorporation
     and By-Laws of the Surviving Corporation until their resignation, removal
     or replacement.


                                       -2-


<PAGE>


          1.6. Conversion of Securities. At the Effective Date, by virtue of the
     Merger and without any action on the part of Prime, Subsidiary or CMT:

          (a) Each issued and outstanding share of the Common Stock and the
     Senior Convertible Preferred Stock of CMT (collectively, the "CMT Stock")
     shall be converted into the right to receive 900 shares (the "Merger
     Consideration") of Common Stock, par value $.01 per share, of Prime (the
     "Prime Stock") against the surrender to CMT of such CMT Stock.

          (b) All shares of the CMT Stock surrendered in exchange for shares of
     Prime Stock, shall be canceled and extinguished by CMT.

          (c) CMT shall issue an aggregate of 100 shares of the common stock of
     CMT to Prime, which shares shall constitute all of the issued and
     outstanding shares of the capital stock of CMT following the Merger.

          (d) Any shares of the capital stock of Subsidiary held in the treasury
     of Subsidiary shall be cancelled and extinguished without any conversion
     thereof and no payment shall be made with respect thereto.

          (e) At the Effective Date, Prime shall surrender for cancellation any
     shares of capital stock of the Subsidiary held by it and the stock transfer
     books of the Subsidiary shall be closed and there shall be no further
     registration of transfers of any shares of the capital stock of the
     Subsidiary thereafter on its records.

          (f) From and after the Effective Date, the holders of certificates
     evidencing ownership of CMT Stock shall cease to have any rights with
     respect to such stock, except as otherwise provided herein or by law.

          (g) Notwithstanding anything to the contrary in this subsection 1.6,
     no party hereto shall be liable to a holder of a certificate or
     certificates formerly representing CMT Stock for any amount properly paid
     to a public official pursuant to any applicable property, escheat or
     similar law.

          (h) No fractional shares of Prime Stock shall be issued in connection
     with the Merger.

          (i) If between the date of this Agreement and the Effective Date the
     outstanding shares of Prime Stock shall have been changed into a different
     number of shares or a different class, by reason of any stock dividend,
     subdivision, reclassification, recapitalization, split-up, combination,
     exchange of shares or the like, the ratio of shares of Prime

                                       -3-


<PAGE>


     Stock to shares of CMT Stock to be issued in the Merger shall be
     correspondingly adjusted.

     2. Representations and Warranties as to CMT. CMT hereby represents and
warrants to Prime and Subsidiary, as follows:

          2.1. Organization, Standing and Power. CMT is a corporation duly
     organized, validly existing and in good standing under the laws of
     Delaware, with full corporate power and authority to own, lease and operate
     its properties and to carry on the Business, as presently conducted by it.
     Except for the state of New Jersey, in which CMT is duly qualified and in
     good standing as a foreign corporation, there are no states or
     jurisdictions in which the character and location of any of the properties
     owned or leased by CMT, or the conduct of its Business, makes it necessary
     for it to qualify to do business as a foreign corporation and where it has
     not so qualified, except for those jurisdictions in which the failure to so
     qualify would not have a materially adverse effect on the Business or
     operations of CMT. Copies of the Certificate of Incorporation of CMT and
     all amendments thereof and the By-laws of CMT, as amended to date, have
     been made available to Prime and are complete and correct. CMT's minute
     books heretofore exhibited to Prime contain complete and accurate records
     of all meetings and other corporate actions of its stockholders and board
     of directors (including committees of its Board of Directors).

          2.2. Capitalization. The authorized capital stock of CMT consists of
     1,000 shares of Senior Convertible Preferred Stock, par value $.01 per
     share (the "Preferred Stock"), 2,000 shares of Class A Voting Common Stock,
     par value $.01 per share (the "Class A Stock"), and 150 shares of Class B
     Non-Voting Convertible Common Stock, par value $.01 per share, of which
     1,000 shares of Preferred Stock and 790 shares of Class A Stock are issued
     and outstanding and are held by various stockholders in the amounts set
     forth in Schedule 2.2 hereof. To the best of the knowledge of CMT, except
     for an aggregate of 128 shares of CMT Stock reserved for issuance upon the
     exercise of outstanding options issued pursuant to the 1997 Stock Option
     Plan, an aggregate of 82 Shares of CMT Stock reserved for issuance upon the
     exercise of options that may be granted in the future under the 1997 Stock
     Option Plan, and 222.22 Shares of CMT Stock reserved for issuance upon the
     exercise of options that may be granted in the future under the 1998 Stock
     Option Plan there are no outstanding options, warrants, rights, calls,
     commitments, conversion rights, puts, plans or other agreements of any
     character to which either CMT or, to the best of the knowledge of CMT, the
     stockholders of CMT is a party or otherwise bound which provide for the
     acquisition or disposition of any of the CMT Stock or any of the securities
     of CMT. All of the CMT Stock has been duly and validly issued and is fully
     paid and nonassessable.


                                       -4-


<PAGE>


          2.3. Interests in Other Entities. CMT does not (a) own, directly or
     indirectly, of record or beneficially, any shares of voting stock or other
     equity securities of any other entity, (b) have any ownership interest,
     direct or indirect, of record or beneficially, in any unincorporated
     entity, or (c) have any obligation, direct or indirect, present or
     contingent, (i) to purchase or subscribe for any interest in, advance or
     loan monies to, or in any way make investments in, any person or entity, or
     (ii) to share any profits or capital investments or both from an entity.

          2.4. Authority.

          (a) The execution and delivery by CMT of this Agreement and of all of
     the agreements to be executed and delivered by it pursuant hereto (the "CMT
     Documents"), the performance by CMT of its obligations hereunder and
     thereunder, and the consummation of the transactions contemplated hereby
     and thereby, have been duly and validly authorized by all necessary
     corporate action on the part of CMT (including, but not limited to, the
     unanimous consent of the stockholders and Board of Directors of CMT) and
     CMT has all necessary power with respect thereto.

          (b) This Agreement is, and when executed and delivered by CMT, the CMT
     Documents to be delivered by it pursuant hereto will be, the valid and
     binding obligation of CMT, enforceable in accordance with its terms,
     subject to the effect of applicable bankruptcy, reorganization, insolvency,
     moratorium and other similar laws of general application relating to,
     limiting or affecting the enforcement of creditors' rights generally and
     general principles of equity that may limit the enforceability of the
     remedies, covenants or other provisions of this Agreement or the CMT
     Documents and the availability of injunctive relief or other equitable
     remedies.

          2.5. Noncontravention. Neither the execution and delivery by CMT of
     the CMT Documents pursuant hereto, nor the consummation of any of the
     transactions contemplated hereby or thereby, nor the performance by CMT of
     its obligations, as the case may be, hereunder or thereunder, will (nor
     with the giving of notice or the lapse of time or both would) (a) conflict
     with or result in a breach of any provision of the Certificate of
     Incorporation or By-laws of CMT, or (b) in any manner which would
     materially affect the ability of CMT to consummate or perform the
     transactions contemplated hereby or have a material adverse effect on the
     business, properties, assets, prospects and operations of CMT (hereinafter,
     a "Material Adverse Effect"), (i) give rise to a default, or any right of
     termination, cancellation or acceleration, or otherwise be in conflict with
     or result in a loss of contractual benefits to CMT or under any of the
     terms, conditions or provisions of any note, bond, mortgage, indenture,
     license, agreement or other instrument or obligation to which it

                                       -5-
 

<PAGE>


     is a party or by which CMT may be bound or to which CMT or the Business may
     be subject, or require any consent, approval or notice under the terms of
     any such document or instrument, or (ii) violate any order, writ,
     injunction, decree, law, statute, rule or regulation of any court or
     governmental authority which is applicable to CMT, or the Business, or
     (iii) result in the creation or imposition of any lien, claim, charge,
     restriction or encumbrance upon any of the properties or assets of CMT, or
     (c) interfere with or otherwise adversely affect the ability of Surviving
     Corporation to carry on the Business after the Effective Date on
     substantially the same basis as is now conducted by CMT.

          2.6. Litigation.

          (a) Except as disclosed on Schedule 2.6, there are no suits or
     actions, or administrative, arbitration or other proceedings or
     governmental investigations, pending or, to the best of the knowledge of
     CMT, threatened, against or relating to CMT or the Business. There are no
     judgments, orders, stipulations, injunctions, decrees or awards in effect
     which relate to CMT, the Business or the operation of the Company, which if
     decided against CMT would have a Material Adverse Effect.

          (b) Schedule 2.6 also lists all products liability claims made or, to
     the best of the knowledge of CMT, threatened against CMT in any of CMT's
     last three fiscal years.

          2.7. Compliance with Law. To the best of the knowledge of CMT, CMT and
     the stockholders of CMT are not engaging in any activity or omitting to
     take any action as a result of which (a) they are in violation of any law,
     rule, regulation, zoning or other ordinance, statute, order, injunction or
     decree, or any other requirement of any court or governmental or
     administrative body or agency, applicable to CMT, its assets or the
     Business ("Laws"), which would have a Material Adverse Effect, which Laws
     include, but are not limited to, those relating to: the use, storage,
     handling, transport or disposal of pollutants, contaminants, pesticides,
     petroleum or petroleum product, asbestos, hazardous or toxic materials or
     wastes, or any substance, whether solid, liquid or gaseous, that is listed,
     defined or regulated as a "hazardous substance", "hazardous waste" or
     "solid waste" or otherwise classified as hazardous or toxic, in or pursuant
     to any Environmental Law (as defined in subparagraph 2.8 hereof), causing
     or posing a threat to cause contamination or adverse effect to the
     environment ("Hazardous Substances"); occupational safety and health;
     business practices and operations; labor practices; employee benefits; and
     zoning and other land use, and (b) CMT, the Business or any of the assets
     of CMT have been or may be materially and adversely affected.


                                       -6-

<PAGE>


          2.8. Environmental Matters.

          (a) (i) The properties and facilities of CMT are not being and, to the
     best of the knowledge of CMT, have never been used to make, store, handle,
     treat, dispose, generate, or transport Hazardous Substances in violation of
     any law; (ii) Hazardous Substances are not and, to the best of the
     knowledge of CMT, have never been made, stored, handled, treated, disposed
     of, generated, or transported on or from the properties and facilities of
     CMT, except in accordance with applicable law now in effect; (iii) the
     properties, facilities and operations of CMT comply and, to the best of the
     knowledge of CMT, have complied in all material respects with all
     applicable Environmental Laws (as defined herein); (iv) none of the
     properties, facilities or operations of CMT is and, to the best of the
     knowledge of CMT, has ever been subject to any judicial or administrative
     proceedings alleging the violation of any Environmental Law; (v) none of
     the properties, facilities or operations of CMT is and, to the best of the
     knowledge of CMT, has ever been the subject of federal, state or local
     investigation evaluating whether any remedial action is needed to respond
     to a release of any Hazardous Substance into the environment; (vi) CMT has
     not filed nor is presently required to file any notice under any federal,
     state, or local law indicating past or present treatment or disposal of a
     Hazardous Substance or reporting a spill or release of a Hazardous
     Substance into the environment; and (vii) CMT has never received notice
     nor, to the best of the knowledge of CMT, is aware of any contingent
     liability in connection with any release of any Hazardous Substance into
     the environment.

          (b) For purposes hereof, "Environmental Laws" means all federal, state
     and local laws, rules, regulations, permits, orders, judgments, injunctions
     and decrees relating to Hazardous Substances applicable to the Business and
     the facilities of CMT (whether or not owned by it). Such laws and
     regulations include, without limitation, the Resource Conservation and
     Recovery Act of 1976 ("RCRA"); the Comprehensive Environmental Response,
     Compensation and Liability Act of 1980 ("CERCLA"); the Toxic Substances
     Control Act; the Clean Water Act; and the Clean Air Act, all as amended
     from time to time; state and federal superlien and environmental cleanup
     programs, including without limitation the New Jersey Industrial Site
     Recovery Act ("ISRA"); and the regulations of the U.S. Department of
     Transportation (with respect to hazardous materials transportation) and the
     Nuclear Regulatory Commission. The term "release" shall have the meanings
     specified in CERCLA and the terms "solid waste" and "disposed," the meaning
     specified in RCRA, as such definitions may be subsequently modified,
     supplemented or amended; provided, however, that in the event either CERCLA
     or RCRA is amended so as to broaden the meaning of any term defined
     thereby, such broader meaning shall apply subsequent to the effective date
     of such amendment; and provided, further, however, that to the extent a
     parcel of real property is

                                       -7-


<PAGE>


     situated in a state or other jurisdiction in which the applicable laws may
     establish a meaning for "release," "solid waste" or "disposal" which is
     broader than that specified in either CERCLA or RCRA, such broader meaning
     shall apply.

          2.9. Financial Statements. CMT has heretofore delivered to Prime and
     Subsidiary audited balance sheets for the years ended December 31, 1997 and
     1996, together with the related statements of operations, changes in
     stockholders' equity and cash flows for the three years ended December 31,
     1997, 1996 and 1995 (collectively, the "Financial Statements"). The
     Financial Statements were prepared in accordance with generally accepted
     accounting principals ("GAAP"), consistently applied, and present fairly
     the financial position of CMT as at the dates thereof and the results of
     operations and the cash flow for the periods indicated. The books and
     records of CMT are complete and correct, have been maintained in accordance
     with good business practices, and accurately reflect the basis for the
     financial condition, results of operations and cash flow of CMT as set
     forth in the Financial Statements.

          2.10. Absence of Undisclosed Liabilities. CMT has no material
     liabilities or obligations of any nature whatsoever, whether accrued,
     absolute, contingent or otherwise, which have not been (a) in the case of
     liabilities and obligations of a type customarily reflected on a corporate
     balance sheet prepared in accordance with GAAP, (1) set forth on the
     Financial Statements or (2) incurred in the ordinary course of business
     since December 31, 1997, or (b) in the case of other types of liabilities
     and obligations, described in any of the schedules delivered pursuant
     hereto or omitted from said schedules in accordance with the terms of this
     Agreement.

          2.11. Accounts Receivables; Inventories.

          (a) The accounts receivable, net of the allowance for doubtful
     accounts applicable thereto (which allowance is established on a basis
     consistent with GAAP) included in the latest balance sheets included in the
     Financial Statements, are at the date hereof collectible in full over the
     period of usual trade terms (by use of CMT's normal collection methods),
     and there do not exist any defenses, counterclaims and set-offs which would
     materially adversely affect such receivables representing obligations for
     the total dollar amount thereof shown on the books of CMT. CMT has
     performed all obligations with respect thereto which they were obligated to
     perform to the date hereof.

          (b) The inventories reflected on the Financial Statements consist of
     items of a quality and quantity usable or saleable in the ordinary course
     of business, except for obsolete materials, slow-moving items, materials of
     below standard quality and not readily marketable items, all of which

                                       -8-

<PAGE>


     (i) have been written down to net realizable value or (ii) have been
     adequately reserved against on the books and records of CMT or (iii) are to
     be marked-down pursuant to CMT's existing inventory practices, consistently
     applied. All inventories are stated at the lower of cost or market in
     accordance with GAAP.


          2.12. Properties. Except for any liens set forth on Schedule 2.12, CMT
     has good and valid title to all of the properties and assets as are
     necessary for the conduct of the Business, as reflected on the Financial
     Statements as owned by it or thereafter acquired, except properties or
     assets sold or otherwise disposed of in the ordinary course of business,
     free and clear of any and all mortgages, liens (including liens for current
     Taxes, as defined in subparagraph 2.15(b) hereof), pledges, claims, charges
     and encumbrances of any nature whatsoever. All plants, structures and
     equipment which are utilized in the Business, or are material to the
     condition (financial or otherwise) of CMT are owned or leased by CMT.
     Schedule 2.12 sets forth all (1) real property which is owned, leased
     (whether as lessor or lessee) or subject to contract or commitment of
     purchase or sale or lease (whether as lessor or lessee) by CMT, or which is
     subject to a title retention or conditional sales agreement or other
     security device, and (2) tangible personal property which is owned, leased
     (whether as lessor or lessee) or subject to contract or commitment of
     purchase or sale or lease (whether as lessor or lessee) by CMT.


          2.13. Intellectual Property.

          (a) CMT owns, or is licensed or otherwise possesses, legally
     enforceable rights to use all patents, trademarks, trade names, service
     marks and copyrights, any applications for and U.S. and foreign
     registrations of such patents, trademarks, trade names, service marks and
     copyrights, and all inventions, discoveries, improvements, processes,
     formulae, methods, schematics, technology, know how, tangible or intangible
     proprietary information, material or rights that are necessary to conduct
     the Business as currently conducted or planned to be conducted by CMT, the
     absence of which would be reasonably likely to have a Material Adverse
     Effect (the "Intellectual Property Rights").

          (b) Annexed hereto as Schedule 2.13 is a list containing a complete
     and correct list of the Intellectual Property Rights of CMT (including a
     summary description and, if applicable, the registration number or other
     authority for use).

          (c) No proceedings have been instituted, are pending or, to the best
     of the knowledge of CMT, are threatened, which challenge the rights of CMT
     in respect to the Intellectual

                                       -9-


<PAGE>


     Property Rights or the validity thereof. To the best of the knowledge of
     CMT, none of the Intellectual Property Rights (or ownership or use thereof)
     violates any laws, statutes, ordinances or regulations, or has at any time
     infringed upon or violated any rights of others, or is being infringed by
     others, or is subject to any outstanding order, decree, judgment,
     stipulation or charge. CMT has not granted any license to third parties
     with regard to the Intellectual Property Rights.

          2.14. Insurance. Annexed hereto as Schedule 2.14 is a complete and
     correct list and summary description of all material policies of insurance
     relating to the Business or in which CMT is an insured party, beneficiary
     or loss payable payee, including without limitation any products liability
     insurance. Such policies are in full force and effect, all premiums due and
     payable with respect thereto have been paid, and no notice of cancellation
     or termination has been received by CMT with respect to any such policy.

          2.15. Tax Matters.

          (a) CMT has filed with the appropriate governmental agencies all tax
     returns and reports required to be filed by it, and has paid in full or
     contested in good faith or made adequate provision for the payment of,
     Taxes (as defined herein) shown to be due or claimed to be due on such tax
     returns and reports. The provisions for Taxes which will be set forth on
     the latest balance sheet included in the Financial Statements reflects and
     includes adequate provisions for the payment in full of any and all Taxes
     for which CMT is or could be liable, whether to any governmental entity or
     to other persons (as, for example, under tax allocation agreements), not
     yet due for any and all periods up to and including the date of such
     balance sheet; and all Taxes for periods beginning thereafter through the
     Effective Date have been, or will be, paid when due or adequately reserved
     against on the books of CMT and an amount of cash equal to the amount of
     such reserve will have been set aside for the payment of such Taxes. CMT
     has duly withheld all payroll taxes, FICA and other federal, state and
     local taxes and other items requiring to be withheld by it from employer
     wages, except to the extent contested in good faith and reserved against,
     and has duly deposited the same in trust for or paid over to the proper
     taxing authorities. CMT has not executed or filed with any taxing authority
     any agreement extending the periods for the assessment or collection of any
     Taxes, and is not a party to any pending or, to the best of the knowledge
     of CMT, threatened, action or proceeding by any governmental authority for
     the assessment or collection of Taxes. Within the past three years, the
     United States federal income tax returns of CMT have not been examined by
     the Internal Revenue Service ("the IRS") nor has the States of Delaware,
     New Jersey, or any taxing authority thereof examined any merchandise,
     personal property, sales or use tax returns of CMT. There is no tax lien,
     whether imposed by any Federal,

                                      -10-


<PAGE>


     state, county, local or foreign taxing authority, outstanding against the
     assets, properties or business of CMT. After the date hereof, no election
     or consent with respect to any Tax (or the computation thereof) affecting
     CMT will be made without the prior written consent of Prime. CMT has not
     agreed to make and is not required to make any adjustment under Section
     481(a) of the Internal Revenue Code, by reason of a change in accounting
     method or otherwise. CMT is not a party to any tax sharing or allocation
     agreement. CMT has not been a member of an affiliated group filing a
     consolidated Federal income tax return and has no liability for Taxes under
     Treas. Reg. ss. 1.1502-6 (or any similar provision of state, local or
     foreign law), as a transferee or successor, by contract or otherwise.

          (b) As used herein, the term "Taxes" or "Tax" means all federal,
     state, county, local and other taxes and governmental assessments,
     including but not limited to income taxes, estimated taxes, withholding
     taxes, excise taxes, ad valorem taxes, payroll related taxes (including but
     not limited to premiums for worker's compensation insurance and statutory
     disability insurance), employment taxes, franchise taxes and import duties,
     together with any related liabilities, penalties, fines, additions to tax
     or interest.

          2.16. Employee Arrangements.

          (a) Schedule 2.16 sets forth a complete and correct list and summary
     description of all (i) union, collective bargaining, employment,
     management, termination and consulting agreements to which CMT is a party
     or otherwise bound, and (ii) compensation plans and arrangements, bonus and
     incentive plans and arrangements, deferred compensation plans and
     arrangements, pension and retirement plans and arrangements, profit-sharing
     and thrift plans and arrangements, stock purchase and stock option plans
     and arrangements, hospitalization and other life, health or disability
     insurance or reimbursement programs, holiday, sick leave, severance,
     vacation, tuition reimbursement, personal loan and product purchase
     discount policies and arrangements, and other plans or arrangements
     providing for benefits for employees of CMT including, without limitation,
     any "employee pension plan" (as defined in Section 3(2) of ERISA) or any
     "employee benefit plan", as such term is defined in Section 3(3) of ERISA,
     whether or not subject to the provisions of ERISA (each such plan,
     contract, policy and arrangement being herein referred to as an "Employee
     Plan"). Said Schedule also lists the names and compensation of all
     employees of CMT whose earnings during the last fiscal year were $50,000 or
     more (including bonuses and other incentive compensation), and all
     employees who are expected to receive at least said amount in respect of
     the current fiscal year. Except as set forth on the CMT Disclosure
     Schedule, none of such personnel is a party and subject to any oral or
     written employment, bonus, pension, profit-sharing, deferred compensation,
     percentage compensation, employee benefit

                                      -11-

<PAGE>


     (including without limitation medical disability, life insurance and other
     welfare benefit plans), incentive, pension or retirement plans, fringe
     benefit or termination or severance agreements, plans or commitments with
     CMT.

          (b) Except for the outstanding indebtedness evidenced by the Notes set
     forth in Exhibit 1.3 hereof, in the aggregate amount of $500,000, to
     certain directors and/or holders of Senior Convertible Preferred Stock of
     CMT, there are no outstanding loans and other advances (other than travel
     advances in the ordinary course of business which do not exceed $3,000
     individually or $10,000 in the aggregate), either (i) made by CMT to any of
     its officers, directors, employees, stockholders, partners or consultants
     or (ii) made by such officers, directors, employees, stockholders, partners
     or consultants to CMT.

          (c) Except as disclosed on Schedule 2.16, there are no pending, or to
     the best of the knowledge of CMT, threatened, labor negotiations, work
     stoppages or work slowdowns involving or affecting the Business, and no
     union representation questions exist, and there are no organizing
     activities, in respect of any of the employees of CMT.

          2.17. Certain Business Matters and Practices

          (a) CMT is not a party to or bound by any material distributorship,
     dealership, sales agency, franchise or similar agreement which relates to
     the Business. CMT does not provide any warranties on its products and has
     no greater obligations than to replace the product sold or as is otherwise
     customary in the industry.

          (b) Set forth on Schedule 2.17 is a description of (i) CMT's rebate
     and volume discount practice, and obligations, (ii) CMT's allowance and
     customer return practice and obligations, (iii) CMT's co-op advertising and
     other promotional practices, (iv) price protection agreements, and (v)
     return policies and historical return rates, as each of the foregoing
     relate to CMT's customers and suppliers.

          2.18. Certain Contracts. Set forth on Schedule 2.18 is a complete and
     correct list of all material contracts, commitments, obligations and
     understandings which are not set forth in any other schedule delivered
     hereunder and to which CMT is a party or otherwise bound, except for each
     of those which (a) was made in the ordinary course of business, and (b)
     either (i) is terminable by CMT (and will be terminable by Prime) without
     liability, expense or other obligation on thirty (30) days' notice or less,
     or (ii) may be anticipated to involve aggregate payments to or by CMT of
     $5,000 (or the equivalent) or less calculated over the full term thereof,
     and (c) is not otherwise material to the Business. Except as set forth in
     the immediately preceding sentence, there are no agreements or

                                      -12-

<PAGE>


     arrangements in effect with respect to the Business by any independent
     salesperson, distributor, sublicensor or other remarketer or sales
     organization. Complete and correct copies of all contracts, commitments,
     obligations and undertakings set forth on any of the Schedules delivered
     pursuant to this Agreement have been furnished by CMT to Prime and
     Subsidiary, and (x) each of them is in full force and effect, no person or
     entity which is a party thereto or otherwise bound thereby is in default
     thereunder, and no event, occurrence, condition or act exists which does
     (or which with the giving of notice or the lapse of time or both would)
     give rise to a default or right of cancellation, acceleration or loss of
     contractual benefits thereunder; (y) there has been no threatened
     cancellations thereof, and (z) there are no outstanding disputes
     thereunder; except, in any of the foregoing cases, where such default,
     cancellation, dispute or the like would not have a Material Adverse Effect.

          2.19. Customers and Suppliers. CMT has no information which might
     reasonably indicate that any of its suppliers or customers have any
     disputes with CMT or the Business or intend to cease selling or rendering
     services to, or dealing with, as applicable, CMT on substantially the same
     basis as of the date hereof, nor has any information been brought to its
     attention which might reasonably lead it to believe any such suppliers or
     customers intend to alter in any material respect the amount of sales or
     services or the extent of dealings with CMT, or would alter in any material
     respect the sales or services or dealings in the event of the consummation
     of the Merger. CMT does not have information which might reasonably
     indicate, nor has any information been brought to its attention which might
     reasonably lead it to believe, that any supplier of CMT will not be able to
     fulfill outstanding or currently anticipated purchase orders placed by, or
     service obligations to, CMT.

          2.20. Approvals/Consents. Except as set forth on Schedule 2.20, to the
     best of the knowledge of CMT, no governmental, administrative third-party
     consents, permits, appointments, approvals, licenses, certificates and
     franchises are necessary for the Business. All such consents, permits,
     appointments, approvals, licenses, certificates and franchises set forth on
     Schedule 2.20 are in full force and effect and will, upon the consummation
     of the Merger, remain in full force and effect without the payment of any
     penalty, the incurrence of any additional debt, liability or obligation of
     any nature whatsoever or the change of any term. No material violations of
     the terms thereof have heretofore occurred or are known by CMT to exist as
     of the date hereof. There are no proceedings pending or, to the best of the
     knowledge of CMT, threatened, or any basis therefor, seeking to cancel,
     terminate or limit such consents, permits, appointments, approvals,
     licenses, certificates, franchises or other authorizations.


                                      -13-

<PAGE>


          2.21. Information as to CMT. None of the representations or warranties
     made by CMT in this Agreement or in any agreement executed and delivered by
     or on behalf of it pursuant hereto are false or misleading with respect to
     any material fact, or omit to state any material fact necessary in order to
     make the statements therein contained not misleading.

     3. Representations and Warranties as to Prime and Subsidiary. Prime and
Subsidiary, as applicable, hereby represent and warrant to CMT, as follows:

          3.1. Organization, Standing and Power. Each of Prime and Subsidiary is
     a corporation duly organized, validly existing and in good standing under
     the laws of the State of Delaware, with full corporate power and authority
     to own, lease and operate its respective properties and to carry on its
     respective business as presently conducted by it. There are no states or
     jurisdictions in which the character and location of any of the properties
     owned or leased by Prime or Subsidiary, or the conduct of their respective
     businesses makes it necessary for them to qualify to do business as a
     foreign corporation and where they have not so qualified, except for those
     jurisdictions in which the failure to so qualify would not have a
     materially adverse effect on the their respective businesses or operations.
     Copies of the Certificates of Incorporation of Prime and Subsidiary and all
     amendments thereof and the By-laws of Prime and Subsidiary, as amended to
     date, have been heretofore made available to CMT.

          3.2. Authority.

          (a) The execution and delivery by Prime and Subsidiary of this
     Agreement and of each agreement, document and instrument to be executed and
     delivered by either or both of them pursuant hereto (the "Prime
     Documents"), the compliance by either or both of them with the provisions
     hereof and thereof, and the consummation of the transactions contemplated
     hereby and thereby, have been duly and validly authorized by all necessary
     corporate actions on the part of Prime and the Subsidiary, and Prime and
     the Subsidiary have all necessary corporate powers with respect thereto.

          (b) This Agreement is, and when executed and delivered by each of
     Prime and the Subsidiary, the Prime Documents to be executed and delivered
     by either or both of them pursuant hereto will be, the valid and binding
     obligation of Prime and the Subsidiary enforceable in accordance with their
     terms, subject to the effect of applicable bankruptcy, reorganization,
     insolvency, moratorium and other similar laws of general application
     relating to, limiting or affecting the enforcement of creditors' rights
     generally and general principles of equity that may limit the
     enforceability of the remedies, covenants or other provisions of this
     Agreement or the Prime

                                      -14-


<PAGE>


     Documents and the availability of injunctive relief or other equitable
     remedies.

          3.3. Noncontravention. Neither the execution and delivery by Prime or
     the Subsidiary of the Prime Documents pursuant hereto, nor the consummation
     of the transactions contemplated hereby or thereby, nor the compliance by
     Prime or the Subsidiary with the provisions hereof and thereof, (a) will
     (nor with the giving of notice or the lapse of time or both, would)
     conflict with or result in a violation of any provision of the Certificates
     of Incorporation or By-laws of Prime and the Subsidiary, or (b) in any
     manner which would materially affect the ability of Prime or Subsidiary to
     consummate the transactions contemplated hereby, (i) give rise to a
     default, or any right of termination, cancellation or acceleration, or
     otherwise be in conflict with or result in a loss of contractual benefits
     to Prime or Subsidiary or under any of the terms, conditions or provisions
     of any note, bond, mortgage, indenture, license, agreement or other
     instrument or obligation to which either of them is a party or by which
     either of them may be bound or to which Prime or Subsidiary may be subject,
     or require any consent, approval or notice under the terms of any such
     document or instrument, or (ii) violate any order, writ, injunction,
     decree, law, statute, rule or regulation of any court or governmental
     authority which is applicable to Prime or Subsidiary, or (iii) result in
     the creation or imposition of any lien, claim, charge, restriction or
     encumbrance upon any of the properties or assets of Prime or Subsidiary.

          3.4. Capitalization. The authorized capital stock of Prime consists of
     20,000,000 shares of Prime Stock and 5,000,000 shares of preferred stock,
     par value of $.01 per share. As of the date hereof, (1) 4,490,500 shares of
     Prime Stock are issued and outstanding, all of which are duly authorized,
     validly issued, fully paid and nonassessable; (2) no shares of preferred
     stock are issued and outstanding; (3) 532,000 shares of Prime Stock are
     issuable upon exercise of options granted by Prime, 242,000 shares of which
     are 10 year options granted under Prime's 1990 Stock Option Plan and (4)
     758,000 shares of Prime Stock are reserved for future issuance under the
     1990 Stock Option Plan. There is no personal liability, and there are no
     preemptive rights with regard to the capital stock of Prime, and no
     right-of-first refusal or similar rights with regard to such capital stock.

          3.5. Merger Consideration. The Merger Consideration, when issued, will
     be (1) duly authorized and validly issued, fully paid and non-assessable,
     (2) delivered hereunder free and clear of any security interests, pledges,
     mortgages, claims, liens and encumbrances of any kind whatsoever except
     that the Prime Stock will be "restricted securities" as such term is
     defined in the rules and regulations of the Securities Exchange Commission
     and will be subject to

                                      -15-
 

<PAGE>



     restrictions on transfers pursuant to such rules and regulations and state
     laws and as otherwise set forth in the Lock-Up Agreement (as defined in
     Section 4.9), and (3) issued in compliance with all applicable federal and
     state securities laws.

          3.6. Litigation. There are no suits or actions, or administrative,
     arbitration or other proceedings or governmental investigations, pending
     or, to the best of the knowledge of Prime and Subsidiary, threatened,
     against or relating to Prime or Subsidiary. There are no judgments, orders,
     stipulations, injunctions, decrees or awards in effect which relate to
     Prime or Subsidiary, their respective business or operations, which if
     decided against either Prime or Subsidiary would have a material adverse
     effect on the businesses, properties, assets, prospects and operations or
     either Prime or Subsidiary.

          3.7. Compliance with Law. To the best of the knowledge of Prime and
     Subsidiary, Prime and Subsidiary are not engaging in any activity or
     omitting to take any action as a result of which they are in violation of
     any Laws applicable to Prime or Subsidiary or any of their respective
     properties or assets, in any manner which would adversely affect the
     ability of Prime or Subsidiary to consummate the transactions provided for
     in this Agreement in accordance with the terms of this Agreement.

          3.8. Absence of Undisclosed Liabilities. Neither Prime nor Subsidiary
     has any material liabilities or obligations of any nature whatsoever,
     whether accrued, absolute, contingent or otherwise which have not been (a)
     in the case of liabilities and obligations of a type customarily reflected
     on a corporate balance sheet prepared in accordance with GAAP, (1) set
     forth in its reports on Forms 10-K and 10-Q for the year ended May 31, 1997
     and each of August 31, 1997, November 30, 1997 and February 28, 1998,
     respectively, on file with the Securities and Exchange Commission (the "SEC
     Filings") or (2) incurred in the ordinary course of business since February
     28, 1998, or (b) in the case of other types of liabilities and obligations,
     described in any of the schedules delivered pursuant hereto or omitted from
     said schedules in accordance with the terms of this Agreement.

          3.9. Information as to Prime and the Subsidiary. None of the
     representations or warranties made by Prime or the Subsidiary in this
     Agreement or in any agreement executed and delivered by or on behalf of
     either or both of them pursuant hereto are false or misleading with respect
     to any material fact, or omit to state any material fact necessary in order
     to make the statements therein contained not misleading.


                                      -16-


<PAGE>


     4. Covenants

          4.1. Investigation.

          (a) Between the date hereof and the earlier of the Effective Date or
     the termination date of this Agreement, Prime and/or Subsidiary, on the one
     hand, and CMT, on the other hand (each an "Investigating Party"), may,
     directly and through their respective representatives, make such
     investigation of the other parties and their respective businesses and
     assets as such Investigating Party deems necessary or advisable; provided,
     that such investigation shall not affect any of the representations and
     warranties contained herein or in any instrument or document delivered
     pursuant hereto. In furtherance of the foregoing, the Investigating Party
     shall have reasonable access, during normal business hours after the date
     hereof, to all properties, books, contracts, commitments and records of
     Prime and/or Subsidiary, on the one hand, or CMT, on the other hand, and
     the party being investigated hereunder shall furnish such financial and
     operating data and other information as may from time to time be reasonably
     requested relating to the transactions contemplated by this Agreement. The
     party being investigated hereunder, and its respective management,
     employees, accountants and attorneys, shall cooperate fully with the
     Investigating Party in connection with any such investigation.

          (b) The Investigating Party shall use its reasonable efforts not to
     disclose or use any confidential information which it obtains in connection
     with any investigation pursuant hereto, except to the extent which it deems
     to be reasonably necessary in order to evaluate the business and operations
     of the other parties hereto. In the event that the Merger is not
     consummated for any reason whatsoever, the Investigating Party shall return
     to the other parties all documents, work papers and other written materials
     which were obtained by it during the course of such investigation which
     constitute confidential information.

          4.2. Consummation of Transaction. Each of the parties hereto hereby
     agrees to use all reasonable efforts to cause all conditions precedent to
     his or its obligations (and to the obligations of the other parties hereto)
     to consummate the transactions contemplated hereby to be satisfied,
     including, but not limited to, using all reasonable efforts to obtain all
     required (if so required by this Agreement) consents, waivers, amendments,
     modifications, approvals, authorizations, novations and licenses; provided,
     however, that nothing herein contained shall be deemed to modify any of the
     absolute obligations imposed upon or rights of any of the parties hereto
     under this Agreement or any agreement executed and delivered pursuant
     hereto.


                                      -17-


<PAGE>


          4.3. Cooperation/Further Assurances.

          (a) Each of the parties hereto hereby agrees to fully cooperate with
     the other parties hereto in preparing and filing any notices, applications,
     reports and other instruments and documents which are required by, or which
     are desirable in the reasonable opinion of any of the parties hereto, or
     their respective legal counsel, in respect of, any statute, rule,
     regulation or order of any governmental or administrative body in
     connection with the transactions contemplated by this Agreement.

          (b) Each of the parties hereto hereby further agrees to execute,
     acknowledge, deliver, file and/or record, or cause such other parties to
     the extent permitted by law to execute, acknowledge, deliver, file and/or
     record such other documents as may be required by this Agreement and as
     Prime and/or Subsidiary, on the one hand, and/or CMT, on the other, or
     their respective legal counsel may reasonably require in order to document
     and carry out the transactions contemplated by this Agreement.

          4.4. Accuracy of Representations. Each party hereto agrees that prior
     to the Closing Date it will enter into no transaction and take no action,
     and will use his or its best efforts to prevent the occurrence of any event
     (but excluding events which occur in the ordinary course of business and
     events over which such party has no control), which would result in any of
     his or its representations, warranties or covenants contained in this
     Agreement or in any agreement, document or instrument executed and
     delivered by him or it pursuant hereto not to be true and correct, or not
     to be performed as contemplated, at and as of the time immediately after
     the occurrence of such transaction or event.

          4.5. Notification of Certain Matters. Each party hereto shall give
     prompt notice to the other parties hereto of (a) the occurrence, or
     nonoccurrence, or any event the occurrence, or nonoccurrence, of which
     would be likely to cause any representation contained in this Agreement to
     be untrue or inaccurate in any material respect at or prior to the
     Effective Date and (b) any material failure by such party giving notice, to
     comply with or satisfy any covenant, condition or agreement to be complied
     with or satisfied by him or it hereunder; provided, however, that the
     delivery of any notice pursuant to this subsection 4.5 shall not limit or
     otherwise affect the remedies available hereunder to the party receiving
     such notice.

          4.6. Broker. Each of the parties hereto represents and warrants to the
     other parties that no broker or finder was engaged or dealt with in
     connection with any of the transactions contemplated by this Agreement, and
     each of the parties shall indemnify and hold the other harmless from and
     against any and all claims or liabilities asserted by or on

                                      -18-


<PAGE>


     behalf of any alleged broker or finder for broker's fees, finder's fees,
     commissions or like payments.

          4.7. Maintenance of Business. CMT will use its commercially reasonable
     efforts to carry on its businesses, keep available the services of its
     officers and employees and preserve its relationships with those of its
     suppliers, licensors, licensees and others having business relationships
     with it that are material to its businesses in substantially the same
     manner as they have prior to the date hereof. If CMT becomes aware of a
     material deterioration or facts which are likely to result in a material
     deterioration in the relationship with any material supplier, licensor,
     licensee or others having business relationships with it, CMT will promptly
     bring such information to the attention of Prime in writing.

          4.8. Stock Option Plan. At the Closing, or as soon thereafter as
     practicable, (a) Prime shall reserve 900 shares of the Prime Stock for
     issuance under Prime's existing 1990 Stock Option Plan for each 1 option to
     purchase shares of Class A Voting Common Stock outstanding at the Closing
     under the Cell & Molecular Technologies, Inc. 1997 Stock Option Plan and
     (b) that the remaining options contained in the Cell & Molecular
     Technologies, Inc. 1997 Stock Option Plan and the entire Cell & Molecular
     Technologies, Inc. 1998 Stock Option Plan become options to purchase Shares
     under Prime's 1990 Stock Option Plan and that Prime reserve shares of Prime
     for issuance thereunder on a 900 to 1 basis, all as set forth on Schedule
     4.8 attached hereto.

          4.9. Lock-Up Agreement. At the Closing, each of the stockholders of
     CMT shall execute and deliver a lock-up agreement, in the form of Exhibit
     4.9 hereunder (the "Lock-up Agreement"), pursuant to which Lock-up
     Agreement each of them would agree not to sell, without the prior consent
     of Prime, their respective shares of Prime Common Stock until the second
     anniversary of the closing of the Merger.

          4.10. Management and Administrative Matters. Prime shall, effective at
     the Closing, take any and all steps or actions reasonably necessary to
     increase the size of the Board of Directors for Prime from three (3) to six
     (6) and, thereafter nominate and elect each of Thomas J. Livelli, Paul
     Marks and Richard Malavarca to serve on such board pursuant to the
     Certificate of Incorporation and By-Laws.

          4.11. Termination of CMT Shareholders' Agreement. Simultaneously with
     the Closing, the Shareholders' Agreement, dated May 20, 1997, by and among
     certain stockholders of CMT is hereby terminated.

     5. Conditions of Merger. The respective obligations of the parties hereto
to effect the Merger shall be subject to

                                      -19-


<PAGE>


the fulfillment at or prior to the Effective Date of the following conditions:

          5.1. Litigation. No order of any court or administrative agency shall
     be in effect which restrains or prohibits the transactions contemplated
     hereby, and no claim, suit, action, inquiry, investigation or proceeding in
     which it will be, or it is, sought to restrain, prohibit or change the
     terms of or obtain damages or other relief in connection with this
     Agreement or any of the transactions contemplated hereby, shall have been
     instituted or threatened by any person or entity, and which, upon the
     advice of either counsel to the parties hereto (based on the reasonable
     likelihood of success and material consequences of such claim, suit,
     action, inquiry or proceeding), makes it inadvisable to proceed with the
     consummation of such transactions.

          5.2. Ratification by the stockholders of CMT. All of the stockholders
     of CMT shall have (a) consented to the transactions herein by the
     affirmative vote of all of such stockholders; and (b) executed and
     delivered Stockholder Representation letters, in substantially the form of
     Exhibit 5.2 hereto (collectively, the "Stockholder Representation
     Letters").

          5.3. No Material Adverse Change. Except as otherwise provided by this
     Agreement, there shall not have occurred prior to the Closing a material
     adverse change in the financial or business condition of CMT, on the one
     hand, or Prime or Subsidiary, on the other hand, in the reasonable judgment
     of the other party.

          5.4. Results of Investigation. Prime and Subsidiary, on the one hand,
     and CMT, on the other hand, shall be satisfied with the results of any "due
     diligence" investigation undertaken by them pursuant to Subsection 4.1
     hereof.

          5.5. Consents and Approvals. All consents, waivers, approvals,
     licenses and authorizations by third parties and governmental and
     administrative authorities (and all amendments or modifications to existing
     agreements with third parties) required as a precondition to the
     performance by CMT of its obligations hereunder and under any agreement
     delivered pursuant hereto, or which in Prime's reasonable judgment are
     necessary to continue unimpaired, subsequent to the Effective Date, any
     rights in and to CMT's assets and/or the Business which could be impaired
     by the Merger, shall have been duly obtained and shall be in full force and
     effect.

          5.6. Fairness Opinion. Unless Prime in its sole discretion shall have
     waived receipt thereof, receipt by Prime of a favorable fairness opinion
     from a reputable investment bank, with respect to the Merger.


                                      -20-

<PAGE>


          5.7. Lock-Up Agreement. Receipt by Prime of the Lock-Up Agreement,
     duly executed by the stockholders of CMT.

          5.8. Date of Consummation. The Merger shall have been consummated on
     or prior to May 31, 1998, or such later date as the parties shall agree by
     a written instrument signed by all of them.

     6. The Closing. Unless this Agreement shall have been terminated and the
transactions herein contemplated shall have been abandoned pursuant to Section
7, the closing of the Merger (the "Closing") will take place at a location
mutually acceptable to the parties hereto as promptly as practicable, but in no
event later than May 31, 1998, or such later date as shall have been fixed by a
written instrument signed by the parties (the "Closing Date"), after the
delivery by the parties hereto of the following upon the terms and conditions of
this Agreement:

          6.1. Deliveries by Prime and Subsidiary. Prime and Subsidiary, as
     applicable, shall deliver:

               (a) stock certificate(s), registered in the name of each of the
          stockholders of CMT, representing their pro rata share of the Merger
          Consideration as set forth in Schedule 2.2 hereof, or duly executed
          instructions to Prime's Transfer Agent, providing for the issuance of
          stock certificates to each of the stockholders of CMT in accordance
          with Schedule 2.2 hereof;

               (b) copies of the resolutions of the Board of Directors of Prime
          and Subsidiary, and the written consent of Prime as the stockholder of
          Subsidiary, authorizing Subsidiary to execute and deliver the Prime
          Documents, to perform its obligations thereunder and to effect the
          Merger, duly certified by the secretaries or assistant secretaries of
          Prime and Subsidiary;

               (c) certificates of the Secretary or Assistant Secretary of
          Subsidiary certifying as to the incumbency and specimen signatures of
          the officers of Subsidiary executing the Prime Documents on behalf of
          such corporation;

               (d) closing certificates from each of Prime and Subsidiary,
          executed by their respective presidents, dated the Closing Date, to
          the effect that: (i) all the representations and warranties of Prime
          or Subsidiary, as the case may be, are true and complete in all
          material respects; (ii) all covenants to be performed by each of Prime
          or Subsidiary, as the case may be, at or as of the Closing have been
          performed in all material respects; and (iii) conditions to be
          satisfied at or as of the Closing have been waived or satisfied in all
          material respects;


                                      -21-


<PAGE>


               (e) confirmation, in the form satisfactory to the parties hereto,
          from the State of Delaware or a filing service (jointly chosen by the
          parties hereto) that the Certificate of Merger of Subsidiary with and
          into CMT has been filed with the Secretary of State of Delaware,
          together with a copy of the executed form of such agreement; and

               (f) the opinion of the law firm of Tenzer Greenblatt LLP, counsel
          for Prime and Subsidiary, dated the Closing Date, substantially in the
          form of Exhibit 6.1(f) hereto.

          6.2. Deliveries by CMT and the stockholders of CMT. CMT and the
     stockholders of CMT, as the case may be, shall deliver to Prime and/or the
     Subsidiary:

               (a) stock certificate(s) representing the CMT Stock;

               (b) copies of the resolutions of the Board of Directors of CMT,
          and the written consent of the stockholders of CMT, authorizing CMT to
          execute and deliver the CMT Documents, to perform its obligations
          thereunder and to effect the Merger, duly certified by the secretary
          or assistant secretary of CMT;

               (c) closing certificates from the President of CMT, dated the
          Closing Date, to the effect that: (i) all the representations and
          warranties of CMT are true and complete in all material respects; and
          (ii) all covenants to be performed by CMT and the stockholders of CMT
          at or as of the Closing have been performed in all material respects;
          and (iii) conditions to be satisfied at or as of the Closing have been
          waived or satisfied in all material respects;

               (d) certificates of the Secretary or Assistant Secretary of CMT
          certifying as to the incumbency and specimen signatures of the
          officers of CMT executing the CMT Documents on behalf of such
          corporation;

               (e) the consents, waivers, approvals, licenses and authorizations
          by third parties and governmental and administrative authorities (and
          all amendments or modifications to existing agreements with third
          parties) required as a precondition to the performance by CMT of its
          obligations hereunder and under any agreement delivered pursuant
          hereto, or which in the parties' reasonable judgment are necessary to
          continue unimpaired, subsequent to the Effective Date, any rights in
          and to the Business which could be impaired by the Merger;

               (f) the Stockholder Representation Letters;

               (g) the Lock-Up Agreements; and


                                      -22-


<PAGE>


               (h) the opinion of the law firm of Littman Krooks Roth & Ball PC,
          counsel for CMT, dated the Closing Date, in substantially the form
          attached hereto as Exhibit 6.2(h).

          6.3. Other Deliveries. In addition, the parties shall execute and
     deliver such other documents as may be required by this Agreement and as
     either of them or their respective counsel may reasonably require in order
     to document and carry out the transactions contemplated by this Agreement.

     7. Termination, Amendment and Waiver.

          7.1. Termination. In the event that any of the conditions set forth in
     Section 5 are not waived or satisfied on or before the Closing Date, this
     Agreement shall, except with respect to subsections 4.1 (b) and 7.2 hereof,
     forthwith become null and void and there shall be no liability on the part
     of any party hereto under any provision hereof; provided, however, that
     notwithstanding the provisions of the foregoing sentence, nothing in this
     Agreement shall relieve any party from liability for any wilful breach of
     the terms hereof.

          7.2. Fees and Expenses. Prime, on the one hand, and CMT, on the other
     hand, shall be responsible for, and shall pay, the fees and expenses
     incurred by each of Prime and the Subsidiary, and CMT, respectively, in
     connection with the Merger and the transactions contemplated by this
     Agreement.

          7.3. Waiver. At any time prior to the Effective Date, any party hereto
     may (a) extend the time for the performance of any of the obligations or
     other acts of the other parties hereto, (b) waive any inaccuracies in the
     representations and warranties contained herein or in any document
     delivered pursuant hereto and (c) waive compliance with any of the
     agreements or conditions contained herein. Any such extension or waiver
     shall be valid if set forth in an instrument in writing signed by the party
     or parties to be bound thereby.

     8. General Provisions.

          8.1. Notices. All notices and other communications given or made
     pursuant hereto shall be in writing and shall be deemed to have been duly
     given or made as of the date received. Notices shall be either delivered
     personally, deposited with courier, sent by telecopy, or mailed by
     registered or certified mail (postage prepaid, return receipt requested),
     to the parties at the following addresses (or at such other address for a
     party as shall be specified by like notice):

If to Prime or Subsidiary:                  Prime Cellular, Inc.
                                            100 First Stamford Place
                                            Stamford, CT  06902


                                      -23-



<PAGE>


                                            Attn: Joseph K. Pagano,
                                            Chairman of the Board and
                                            Chief Executive Officer
                                            Fax: (203) 359-0880

with a copy to:                             Tenzer Greenblatt LLP
                                            405 Lexington Avenue
                                            New York, New York 10174

                                            Attn: Robert J. Mittman, Esq.
                                            Fax:  (212) 885-5001


If to CMT:                                  Cell & Molecular Technologies, Inc.
                                            406 Grand Central Avenue
                                            Lavalette, New Jersey  08735

                                            Attn: Thomas J. Livelli
                                            President and Chief Executive
                                               Officer
                                            Fax: (732) 830-4594

with a copy to:                             Littman Krooks Roth & Ball PC
                                            655 Third Avenue
                                            New York, New York  10017

                                            Attn: Mitchell Littman, Esq.
                                            Fax:  (212) 490-2990

          8.2. Severability. If any term or other provision of this Agreement is
     invalid, illegal or incapable of being enforced by any rule of law, or
     public policy, all other conditions and provisions of this Agreement shall
     nevertheless remain in full force and effect so long as the economic or
     legal substance of the transactions contemplated hereby is not affected in
     any manner adverse to any party. Upon such determination that any term or
     other provision is invalid, illegal or incapable of being enforced, the
     parties hereto shall negotiate in good faith to modify this Agreement so as
     to effect the original intent of the parties as closely as possible in an
     acceptable manner to the end that transactions contemplated hereby are
     fulfilled to the greatest extent possible.

          8.3. Entire Agreement. This Agreement and the agreements referred to
     herein constitute the entire agreement, and supersede all prior agreements,
     representations and undertakings, both written and oral, among the parties,
     or any of them, with respect to the subject matter hereof.

          8.4. Amendment. This Agreement may not be amended except by an
     instrument in writing signed by each of the parties hereto.


                                      -24-

<PAGE>


          8.5. No Assignment. This Agreement shall not be assigned by operation
     of law or otherwise, and any assignment shall be null and void.

          8.6. Governing Law. This Agreement shall be governed by, and construed
     in accordance with, the law of the State of New York, without regard to its
     choice of law principles.

          8.7. Counterparts. This Agreement may be executed in one or more
     counterparts, and by the different parties hereto in separate counterparts,
     each of which when so executed shall be deemed to be an original, but all
     of which taken together shall constitute one and the same agreement.


                                      -25-


<PAGE>


     IN WITNESS WHEREOF, each of the parties hereto, have caused this Agreement
to be executed as of the date first written above.

                                            PRIME CELLULAR, INC.


                                            By: /s/ Joseph K. Pagano
                                              ----------------------------------
                                                Joseph K. Pagano, President



                                            CMT ACQUISITION CORP.


                                            By: /s/ Joseph K. Pagano
                                              ----------------------------------
                                               Joseph K. Pagano, President



                                            CELL & MOLECULAR TECHNOLOGIES, INC.


                                            By: /s/ Thomas J. Livelli
                                               ---------------------------------
                                               Thomas J. Livelli, President





                                      -26-




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission